Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  9, 213 - 219 (2003)
Published online: 13 January 2003; | doi:10.1038/nm820

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

Sean B. Joseph1, 3, Antonio Castrillo1, 3, Bryan A. Laffitte1, David J. Mangelsdorf2 & Peter Tontonoz1

1  Howard Hughes Medical Institute, Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California, USA

2  Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

3  S.B.J. and A.C. contributed equally to this work.

Correspondence should be addressed to Peter Tontonoz ptontonoz@mednet.ucla.edu
Macrophages have important roles in both lipid metabolism and inflammation and are central to the pathogenesis of atherosclerosis. The liver X receptors (LXRs) are established mediators of lipid-inducible gene expression, but their role in inflammation and immunity is unknown. We demonstrate here that LXRs and their ligands are negative regulators of macrophage inflammatory gene expression. Transcriptional profiling of lipopolysaccharide (LPS)-induced macrophages reveals reciprocal LXR-dependent regulation of genes involved in lipid metabolism and the innate immune response. In vitro, LXR ligands inhibit the expression of inflammatory mediators such as inducible nitric oxide synthase, cyclooxygenase (COX)-2 and interleukin-6 (IL-6) in response to bacterial infection or LPS stimulation. In vivo, LXR agonists reduce inflammation in a model of contact dermatitis and inhibit inflammatory gene expression in the aortas of atherosclerotic mice. These findings identify LXRs as lipid-dependent regulators of inflammatory gene expression that may serve to link lipid metabolism and immune functions in macrophages.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
The liver X receptor gene team: Potential new players in atherosclerosis
Nature Medicine Review Article (01 Nov 2002)
The macrophage foam cell as a target for therapeutic intervention
Nature Medicine Review Article (01 Nov 2002)
 See all 4 matches for Reviews

NEWS AND VIEWS
eLiXiRs for restraining inflammation
Nature Medicine News and Views (01 Feb 2003)

RESEARCH
Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation
The EMBO Journal Article (15 Sep 2003)
PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
Nature Medicine Article (01 Jan 2001)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Figures & Tables
Supplementary info
See also: News and Views by Freeman & Moore
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy